Given the similarities between canine cognitive dysfunction syndrome (CDS) and Alzheimer’s disease (AD) in humans, particularly in amyloid precursor protein (APP) processing, amyloid plaque deposition, and cognitive impairment [7], studies have investigated shared pathophysiological markers. This evidence concerns the gene APP and cerebral creatine deficiency syndrome.